Biotechnology

A landmark survey shows medical cannabis helps 97% of mental health patients, but experts urge caution, highlighting a divide between patient experience and clinical proof.

A plant-based bomber jacket is hitting the mainstream. Is this the blueprint for fashion's sustainable future or just another high-profile experiment?

A breakthrough system grows larger, more complex human gut tissues twice as fast, promising to revolutionize drug testing and regenerative medicine.

Caliway Biopharma advances its fat-loss drug, promising objective, MRI-verified results in a market hungry for safer, more reliable aesthetic options.

Gene Solutions' AI-driven multi-omics liquid biopsy platform makes waves at a major oncology conference, finding a ready market in Taiwan.

Pliant Therapeutics heads to ASCO with data on a novel drug designed to reawaken the immune system's attack on advanced, treatment-resistant tumors.

New data shows Moleculin Biotech's Annamycin avoids heart toxicity, a breakthrough that could transform treatment for leukemia and sarcoma patients.

At SLAS 2026, MGI Tech unveiled intelligent platforms for proteomics and clinical automation, signaling a major push to accelerate scientific discovery.

A new partnership is tackling a national skills gap by showing students the high-tech, world-changing reality of modern biomanufacturing. Here's how.

A Seattle biotech's award-winning vaccine for a deadly fever is now in human trials, powered by innovative tech that could change global vaccine deployment.

Pioneers of IVF technology are launching a clinical skincare program, aiming to merge cellular science with holistic patient support in fertility clinics.

Central Ohio cancer patients gain unprecedented access to advanced therapies and clinical trials as Zangmeister Cancer Center joins OSU's James Cancer Network.

With new CEO Andrew Zeringue, Theromics aims to tackle cancer recurrence with its HeatSYNC gel, a novel approach in the booming ablation market.

A potential first-in-class antibody-drug conjugate for colorectal cancer begins a pivotal trial, aiming to help patients who have run out of options.

By hiring a third former FDA oncology leader, Precision for Medicine creates an unparalleled regulatory brain trust to speed up cancer drug approvals.

A powerful new combination therapy from Junshi Biosciences and RemeGen gains approval in China, offering unprecedented hope for urothelial carcinoma patients.

A new partnership combines AI-driven precision with deep gene therapy expertise, aiming to overcome critical safety hurdles and redefine treatment for rare diseases.

A breakthrough NAMI microencapsulation tech ensures probiotics survive stomach acid, promising a new standard of health and wellness for cats and dogs.

With final court approval, Crescita Therapeutics will be delisted from the TSX as global platform ClinActiv snaps up its dermatology assets.

A landmark advocacy effort secures official recognition for clinical research professionals, shining a light on a workforce facing critical shortages and burnout.